Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geriatric Medicines Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Analgesics
1.2.3 Antihypertensives
1.2.4 Statins
1.2.5 Antidiabetics
1.2.6 Proton Pump Inhibitor
1.2.7 Anticoagulant
1.2.8 Antipsychotics
1.2.9 Antidepressants
1.3 Market by Application
1.3.1 Global Geriatric Medicines Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cardiovascular diseases
1.3.3 Arthritis
1.3.4 Neurological Disorders
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Geriatric Medicines Market Perspective (2018-2033)
2.2 Geriatric Medicines Growth Trends by Region
2.2.1 Global Geriatric Medicines Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Geriatric Medicines Historic Market Size by Region (2018-2023)
2.2.3 Geriatric Medicines Forecasted Market Size by Region (2024-2033)
2.3 Geriatric Medicines Market Dynamics
2.3.1 Geriatric Medicines Industry Trends
2.3.2 Geriatric Medicines Market Drivers
2.3.3 Geriatric Medicines Market Challenges
2.3.4 Geriatric Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geriatric Medicines Players by Revenue
3.1.1 Global Top Geriatric Medicines Players by Revenue (2018-2023)
3.1.2 Global Geriatric Medicines Revenue Market Share by Players (2018-2023)
3.2 Global Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Geriatric Medicines Revenue
3.4 Global Geriatric Medicines Market Concentration Ratio
3.4.1 Global Geriatric Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicines Revenue in 2022
3.5 Geriatric Medicines Key Players Head office and Area Served
3.6 Key Players Geriatric Medicines Product Solution and Service
3.7 Date of Enter into Geriatric Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geriatric Medicines Breakdown Data by Type
4.1 Global Geriatric Medicines Historic Market Size by Type (2018-2023)
4.2 Global Geriatric Medicines Forecasted Market Size by Type (2024-2033)
5 Geriatric Medicines Breakdown Data by Application
5.1 Global Geriatric Medicines Historic Market Size by Application (2018-2023)
5.2 Global Geriatric Medicines Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Geriatric Medicines Market Size (2018-2033)
6.2 North America Geriatric Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Geriatric Medicines Market Size by Country (2018-2023)
6.4 North America Geriatric Medicines Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Geriatric Medicines Market Size (2018-2033)
7.2 Europe Geriatric Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Geriatric Medicines Market Size by Country (2018-2023)
7.4 Europe Geriatric Medicines Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Geriatric Medicines Market Size (2018-2033)
8.2 Asia-Pacific Geriatric Medicines Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Geriatric Medicines Market Size by Region (2018-2023)
8.4 Asia-Pacific Geriatric Medicines Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Geriatric Medicines Market Size (2018-2033)
9.2 Latin America Geriatric Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Geriatric Medicines Market Size by Country (2018-2023)
9.4 Latin America Geriatric Medicines Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geriatric Medicines Market Size (2018-2033)
10.2 Middle East & Africa Geriatric Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Geriatric Medicines Market Size by Country (2018-2023)
10.4 Middle East & Africa Geriatric Medicines Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Geriatric Medicines Introduction
11.1.4 Eli Lilly and Company Revenue in Geriatric Medicines Business (2018-2023)
11.1.5 Eli Lilly and Company Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Geriatric Medicines Introduction
11.2.4 AstraZeneca Revenue in Geriatric Medicines Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Geriatric Medicines Introduction
11.3.4 Boehringer Ingelheim Revenue in Geriatric Medicines Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Geriatric Medicines Introduction
11.4.4 Abbott Laboratories Revenue in Geriatric Medicines Business (2018-2023)
11.4.5 Abbott Laboratories Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Geriatric Medicines Introduction
11.5.4 Sanofi Revenue in Geriatric Medicines Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Geriatric Medicines Introduction
11.6.4 Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2018-2023)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Geriatric Medicines Introduction
11.7.4 Merck Revenue in Geriatric Medicines Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Geriatric Medicines Introduction
11.8.4 Novartis Revenue in Geriatric Medicines Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Geriatric Medicines Introduction
11.9.4 Pfizer Revenue in Geriatric Medicines Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 GSK
11.10.1 GSK Company Detail
11.10.2 GSK Business Overview
11.10.3 GSK Geriatric Medicines Introduction
11.10.4 GSK Revenue in Geriatric Medicines Business (2018-2023)
11.10.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Geriatric Medicines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Analgesics
Table 3. Key Players of Antihypertensives
Table 4. Key Players of Statins
Table 5. Key Players of Antidiabetics
Table 6. Key Players of Proton Pump Inhibitor
Table 7. Key Players of Anticoagulant
Table 8. Key Players of Antipsychotics
Table 9. Key Players of Antidepressants
Table 10. Global Geriatric Medicines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Geriatric Medicines Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Geriatric Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Geriatric Medicines Market Share by Region (2018-2023)
Table 14. Global Geriatric Medicines Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 15. Global Geriatric Medicines Market Share by Region (2024-2033)
Table 16. Geriatric Medicines Market Trends
Table 17. Geriatric Medicines Market Drivers
Table 18. Geriatric Medicines Market Challenges
Table 19. Geriatric Medicines Market Restraints
Table 20. Global Geriatric Medicines Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Geriatric Medicines Market Share by Players (2018-2023)
Table 22. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2022)
Table 23. Ranking of Global Top Geriatric Medicines Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Geriatric Medicines Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Geriatric Medicines Product Solution and Service
Table 27. Date of Enter into Geriatric Medicines Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Geriatric Medicines Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Geriatric Medicines Revenue Market Share by Type (2018-2023)
Table 31. Global Geriatric Medicines Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 32. Global Geriatric Medicines Revenue Market Share by Type (2024-2033)
Table 33. Global Geriatric Medicines Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Geriatric Medicines Revenue Market Share by Application (2018-2023)
Table 35. Global Geriatric Medicines Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 36. Global Geriatric Medicines Revenue Market Share by Application (2024-2033)
Table 37. North America Geriatric Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Geriatric Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Europe Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 43. Asia-Pacific Geriatric Medicines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 44. Asia-Pacific Geriatric Medicines Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Geriatric Medicines Market Size by Region (2024-2033) & (US$ Million)
Table 46. Latin America Geriatric Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Latin America Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 49. Middle East & Africa Geriatric Medicines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 50. Middle East & Africa Geriatric Medicines Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Geriatric Medicines Market Size by Country (2024-2033) & (US$ Million)
Table 52. Eli Lilly and Company Company Detail
Table 53. Eli Lilly and Company Business Overview
Table 54. Eli Lilly and Company Geriatric Medicines Product
Table 55. Eli Lilly and Company Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 56. Eli Lilly and Company Recent Development
Table 57. AstraZeneca Company Detail
Table 58. AstraZeneca Business Overview
Table 59. AstraZeneca Geriatric Medicines Product
Table 60. AstraZeneca Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 61. AstraZeneca Recent Development
Table 62. Boehringer Ingelheim Company Detail
Table 63. Boehringer Ingelheim Business Overview
Table 64. Boehringer Ingelheim Geriatric Medicines Product
Table 65. Boehringer Ingelheim Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 66. Boehringer Ingelheim Recent Development
Table 67. Abbott Laboratories Company Detail
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Geriatric Medicines Product
Table 70. Abbott Laboratories Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 71. Abbott Laboratories Recent Development
Table 72. Sanofi Company Detail
Table 73. Sanofi Business Overview
Table 74. Sanofi Geriatric Medicines Product
Table 75. Sanofi Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Bristol-Myers Squibb Company Detail
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Geriatric Medicines Product
Table 80. Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Merck Company Detail
Table 83. Merck Business Overview
Table 84. Merck Geriatric Medicines Product
Table 85. Merck Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Novartis Company Detail
Table 88. Novartis Business Overview
Table 89. Novartis Geriatric Medicines Product
Table 90. Novartis Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Pfizer Company Detail
Table 93. Pfizer Business Overview
Table 94. Pfizer Geriatric Medicines Product
Table 95. Pfizer Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. GSK Company Detail
Table 98. GSK Business Overview
Table 99. GSK Geriatric Medicines Product
Table 100. GSK Revenue in Geriatric Medicines Business (2018-2023) & (US$ Million)
Table 101. GSK Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geriatric Medicines Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Geriatric Medicines Market Share by Type: 2022 VS 2033
Figure 3. Analgesics Features
Figure 4. Antihypertensives Features
Figure 5. Statins Features
Figure 6. Antidiabetics Features
Figure 7. Proton Pump Inhibitor Features
Figure 8. Anticoagulant Features
Figure 9. Antipsychotics Features
Figure 10. Antidepressants Features
Figure 11. Global Geriatric Medicines Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 12. Global Geriatric Medicines Market Share by Application: 2022 VS 2033
Figure 13. Cardiovascular diseases Case Studies
Figure 14. Arthritis Case Studies
Figure 15. Neurological Disorders Case Studies
Figure 16. Cancer Case Studies
Figure 17. Osteoporosis Case Studies
Figure 18. Respiratory Case Studies
Figure 19. Other Case Studies
Figure 20. Geriatric Medicines Report Years Considered
Figure 21. Global Geriatric Medicines Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 22. Global Geriatric Medicines Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 23. Global Geriatric Medicines Market Share by Region: 2022 VS 2033
Figure 24. Global Geriatric Medicines Market Share by Players in 2022
Figure 25. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2022)
Figure 26. The Top 10 and 5 Players Market Share by Geriatric Medicines Revenue in 2022
Figure 27. North America Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. North America Geriatric Medicines Market Share by Country (2018-2033)
Figure 29. United States Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Canada Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Europe Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Europe Geriatric Medicines Market Share by Country (2018-2033)
Figure 33. Germany Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. France Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. U.K. Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Italy Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Russia Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Nordic Countries Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Geriatric Medicines Market Share by Region (2018-2033)
Figure 41. China Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Japan Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Latin America Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Latin America Geriatric Medicines Market Share by Country (2018-2033)
Figure 49. Mexico Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Brazil Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Middle East & Africa Geriatric Medicines Market Share by Country (2018-2033)
Figure 53. Turkey Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Geriatric Medicines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Eli Lilly and Company Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 56. AstraZeneca Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 58. Abbott Laboratories Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 59. Sanofi Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 61. Merck Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 62. Novartis Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 63. Pfizer Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 64. GSK Revenue Growth Rate in Geriatric Medicines Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed